Visualase, Inc. was founded in 2005 as a spin-off from BioTex, Inc., the original developer and current manufacturer of the Visualase technology. Visualase, Inc. is currently a privately held company located in Houston, Texas.
Research and Development
Visualase, Inc. is focused in product development, clinical evaluations, manufacturing, and marketing of advanced laser and image-guided technologies for thermal ablation markets. Our goal is to provide physicians with a superior platform for minimally invasive thermal tumor therapy and merge existing diagnostic and therapeutic environments for improved patient care.
For information regarding investment in Visualase, Inc. and its array of technologies, please contact us. Presentations are available for download in PDF and Powerpoint format upon request.
Bill Hoffman, CEO Bill Hoffman has extensive commercial execution experience with early stage medical device companies, especially those focused on novel and potentially disruptive technologies. Bill’s most recent position was Chief Operating Officer at Rubicor Medical, a Northern California based company focused on an image guided, percutaneous lumpectomy device, as well as a novel hand held breast biopsy device. He hired the executive team, helped raise $27.5M Series C commercialization funds, and brought both products to market within 18 months. Prior to that, Bill was Vice President of Sales at FoxHollow Inc., building from scratch a team of 250 sales professionals, and driving arguably the fastest, most explosive revenue ramp in the history of medical device sales: from no revenue in Q2 2003 to $138M in calendar year 2005. Bill’s first experience in early stage commercialization was at RITA Medical Systems, the first volumetric, radiofrequency ablation company in the US. As Director of US Sales, he executed the hiring plan and revenue growth ramp that resulted in a successful IPO in 2000.
Ashok Gowda Ph.D., Founder and COO Dr. Gowda has over 10 years experience in directing medical device technology development and has contributed to the Visualase effort on both the scientific and management fronts. Dr. Gowda currently oversees a number of aspects of the Visualase commercialization effort, including organizing clinical collaborations, maintaining a strong intellectual property program, and ensuring adequate financial and personnel resources to fulfill the Company vision. Dr. Gowda received his B.E. degree in Biomedical Engineering from Vanderbilt University in 1991 and the M.S. and Ph.D. degrees in Bioengineering from Texas A&M University in 1998.
Linda Spain, CFO Ms. Spain has 38 years of business experience, mostly in finance and business development. For the past 12 years, she has served as board member, advisor, and interim officer for early-stage companies commercializing technology. She has extensive experience with acquisitions/divestitures, purchase and supply agreements, debt and equity financings, and structuring strategic alliances. Her transaction experience includes both large and small transactions, totaling billions of dollars in multiple industries. Additionally, she was recognized by the National Association of Corporate Directors with an invitation to be a founding director of its Houston chapter. Ms. Spain has a BA in economics from Rice University.
Andre G. Marquette VP of Marketing, Prior to joining Visualase, Mr. Marquette spent nearly 20 years in early stage health care ventures, primarily VC backed start-ups. His experience includes leadership roles in marketing, business development, and international at St. Jude Medical-Neuromodulation (DBS), Nanospectra, Cyberonics, and EmCare. During his 12 years at Cyberonics, he was responsible for the pre-FDA approval marketing activities and the eventual US launch of the Vagus Nerve Stimulation System for Epileptogenic Foci in 1997. At Cyberonics, he was also part of the original team to create the VNS strategy, execute the company’s IPO and secondary offerings, and obtain PMA FDA approval. During his tenure cumulative sales grew from $0 to more than $800 million with a market cap of $1.2 billion. Mr. Marquette was also part of the management team at EmCare when the company was sold for $400 million to AMR, Inc. Mr. Marquette has a BA in Biology from The University of Texas at Austin and an MBA from Rice University.
Andrew Keene, Director of Business Development, has over 20 years of medical sales experience mostly in early stage companies commercializing novel medical devices in new markets. Prior to joining Visualase, Andrew was part of the original sales and management team at Foxhollow. Andrew was instrumental in building both the PAD market and company sales of over $138M. Foxhollow had a successful IPO in 2004, was eventually sold to EV3. Prior to that Andrew, was the first sales manager hired to help to build and manage the sales team at Rita Medical. Rita developed and commercialized the first volumetric RF ablation technology, and Andrew’s efforts led to a successful IPO in 2000 and an eventual acquisition by Angiodynamics. Before helping to bring emerging technologies to market, Andrew held various sales and sales management positions at Medtronic and Johnson & Johnson’s Ethicon division.
Michael Jerome, Director of Neuro Applications, has 16 years of award winning sales experience in medical sales, mostly in early stage companies commercializing novel medical technologies. Prior to joining Visualase, Michael was the first member of the commercialization team for AccessClosure. Michael ran the new hire training as well as a successful team in the Northeast. Michael played a large role in AccessClosure achieving 72 million in sales in its second full year of commercialization. Prior to that, Micheal was part of Foxhollow Technologies. He Launched the technology and created the atherectomy market in Upstate New York and parts New England. He created a very successful territory and held several training positions, including Director of Training. Prior to that, he spent three years at Cyberonics and has experience and understanding of the epilepsy market. Before his starting his carer in the start up realm, he worked for Abbott Laboratories.
Robert R. Tillman, Member, Board of Directors Mr. Tillman is a member of the board of directors of Visualase, Inc. and currently operates as a mergers and acquisitions, turnaround and startup business consultant when not employed full-time in an operating role. He has served as President and CEO at RRTI, Inc., Rootsweb.com, Inc., Storm Technology, Inc., and Sunshine Medical Instruments, Inc. As a Product Marketing Manager at Nellcor Incorporated, he authored both the business plan and the FDA application for the first commercially successful noninvasive pulse oximeter. Mr. Tillman holds a B.A. degree from Harvard University and an M.B.A. degree from the Stanford University Graduate School of Business.
In Remembrance: Roger McNichols, Ph.D. (1969-2012)
Dr. McNichols was co-founder of Visualase, Inc., and co-inventor of the Visualase Thermal Therapy System. He received his Ph.D. in Biomedical Engineering from Texas A&M University and subsequently contributed to the development of multiple medical devices involving optical sensors and lasers. Dr. McNichols was a brilliant colleague and a genuine friend to all who worked with him, and he is greatly missed.